Tetrahydrocannabinol and endocannabinoids in feeding and appetite

Pharmacology and Therapeutics

Volumn 95, Issue 2, 2002, Pages 185-190

  Berry, Elliot M ^a   Mechoulam, Raphael ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

2 Arachidonoylglycerol; Anandamide; Cannabinoid receptors; Leptin; SR141716A; Suckling

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; RIMONABANT; TETRAHYDROCANNABINOL;

ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; CACHEXIA; DRUG EFFECT; DRUG MECHANISM; FEEDING; HUMAN; NEUROMODULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; SATIETY; SUCKLING; WEIGHT REDUCTION;

EID: 0036669295     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00257-7     Document Type: Review

References (63)

1. Abel E.L. Effects of marihuana on the solution of anagrams, memory and appetite. Nature. 231:1971;260-261.
2. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR 141176, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology. 132:1997;104-106.
3. Balog D.S., Epstein M.E., Amodio-Groton M.I. HIV wasting syndrome. Ann Pharmacother. 32:1998;446-458.
4. Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., Lefkowitz L., Plasse T.F., Shepard K.V. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Sympt Manage. 10:1995;89-97.
5. Beal J.E., Olson R., Lefkowitz L., Laubensteind L., Bellman P., Yangco B., Morales J.O., Murphy R., Powderly W., Plasse T.F., Mosdell K.W., Shepard K.V. Long-term efficacy and safety for acquired immunodeficiency syndrome-associated anorexia. J Pain Sympt Manage. 14:1997;7-14.
6. Ben-Shabat S., Fride E., Sheskin T., Tamiri T., Rhee M.-H., Vogel Z., Bisogno T., De Petrocellis L., Di Marzo V., Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol. 353:1998;23-31.
7. Berger A., Crozier G., Bisogno T., Cavaliere P., Innis S., Di Marzo V. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA. 98:2001;6402-6406.
8. Berry E.M., Marcus E.-L. Disorders of eating in the elderly. J Adult Dev. 7:2000;87-99.
9. Birch E.A. The use of Indian hemp in the treatment of chronic chloral and chronic opium poisoning. Lancet. i:1889;625.
10. British Nutrition Foundation Unsaturated Fatty Acids. 1992;Chapman and Hall, London.
11. Calhoun S.R., Galloway G.P., Smith D.E. Abuse potential of dronabinol (Marinol). J Psychoactive Drugs. 30:1998;187-196.
12. Chaperon F., Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol. 13:1999;243-281.
13. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63:1998;PL113-PL117.
14. A1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA. 97:2000;13384-13389.
15. De Petrocellis L., Melck D., Bisogno T., Milone A., Di Marzo V. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience. 92:1999;377-387.
16. Devane W.A., Dysarz F.A. III, Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 35:1988;605-613.
17. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
18. Di Marzo V., Melck D., Bisogno T., De Petrocollis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
19. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batki S., Jari Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 410:2001;822-825.
20. Donovan M. On the physical and medicinal qualities of Indian hemp (Cannabis indica). Dublin J Med Sci. 26:1845;368-402.
21. Elsmore T.F., Fletcher G.V. Delta-9-THC: aversive effects in rat at high doses. Science. 175:1972;911-912.
22. Freedland C.S., Sharpe A.L., Samon H.H., Porrino L.J. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res. 25:2001;277-282.
23. Fride E., Ginzburg Y., Breuer A., Bisogno T., Di Marzo V., Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol. 419:2001;207-214.
24. Friedman J.M. Obesity in the new millennium. Nature. 404:2000;632-634.
25. Gaoni Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Amer Chem Soc. 86:1964;1646.
26. Giuliani D., Ottani A., Ferrari F. Effects of the cannabinoid receptor agonist, HU-210, on ingestive hehavior and body weight of rats. Eur J Pharmacol. 391:2000;275-279.
27. Gonzalez-Rosales F., Walsh D. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). J Pain Symptom Manage. 14:1997;311-314.
28. Gross H., Ebert M.H., Faden V.B., Goldberg S.C., Kaye W.H., Caine E.D., Hawks R., Zinberg N.A. A double blind trial of delta-9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol. 3:1983;165-171.
29. 1 receptor. Proc Natl Acad Sci USA. 98:2001;3662-3665.
30. Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet restricted mice. Eur J Pharmacol. 392:2000;147-156.
31. Huestis M.A., Gorelick D.A., Heishman S.J., Preston K.L., Nelson R.A., Moolchan E.T., Frank R.A. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry. 58:2001;322-328.
32. Joy J.E., Watson S.J. Jr., Benson J.A. Jr. Marijuana and Medicine. 1999;National Academy Press, Washington, D.C.
33. Kirkham T.C., Williams C.M. Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology. 153:2001;267-270.
34. Kirkham T.C., Williams C.M. Endogenous cannabinoids and appetite. Nutr Res Rev. 14:2001;65-86.
35. 1 receptors and obesity. Symposium on the Cannabinoids, San Lorenzo de El Escorial, Spain, June 28-30. 2001;101 International Cannabinoid Research Society, Burlington.
36. Leibowitz S.F., Akabayashi A., Wang J. Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci. 18:1998;2709-2719.
37. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
38. McLaughlin C.L., Baile C.A., Bender P.E. Cannabinoids and feeding in sheep. Psychopharmacology. 64:1979;321-323.
39. Mechoulam R. The pharmacohistory of Cannabis sativa. Mechoulam R. Cannabinoids as Therapeutic Agents. 1986;1-18 CRC Press, Boca Raton.
40. Mechoulam R., Ben-Shabat S. From Gan-Zi-Gun-Nu to anandamide and 2-arachidonoyl-glycerol, the ongoing story of cannabis. Nat Prod Rep. 16:1999;131-143.
41. Mechoulam R., Fride E. A hunger for cannabinoids. Nature. 410:2001;763-765.
42. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 50:1995;83-90.
43. Mechoulam R., Fride E., Di Marzo V. Endocannabinoids. Eur J Pharmacol. 359:1998;1-18.
44. Moolenaar W.H. Development of our current understanding of bioactive lysophospholipids. Ann NY Acad Sci. 905:2000;1-10.
45. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
46. Nelson K., Walsh D., Deeter P., Sheehan F. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care. 10:1994;14-18.
47. Paton W.D.M., Pertwee R.G. The pharmacology of cannabis in animals. Mechoulam R. Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects. 1973;191-285 Academic Press, New York and London.
48. Paton W.D.M., Pertwee R.G. The actions of cannabis in man. Mechoulam R. Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects. 1973;287-333 Academic Press, New York and London.
49. 2 receptors. Pharmacol Ther. 74:1997;129-180.
50. Rahminiwati M., Nishimura M. Effects of delta-9-THC and diazepam on feeding behaviour in mice. J Vet Med Sci. 61:1999;351-355.
51. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
52. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
53. Shoham S., Marcus E.L., Avraham Y., Berry E.M. Diet restriction increases enkephalin- and dynorphin-like immunoreactivity in rat brain and attenuates long-term retention of passive avoidance. Nutr Neurosci. 3:2000;41-55.
54. 1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol. 9:1998;179-181.
55. Sofia R.D., Knobloch L.C. Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav. 4:1976;591-599.
56. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 215:1995;89-97.
57. Sulcova E., Mechoulam R., Fride E. Biphasic effects of anandamide. Pharmacol Biochem Behavior. 59:1998;347-353.
58. Trojniar W., Wise R.A. Facilitatory effect of delta-9-THC on hypothalmically induced feeding. Psychopharmacology. 103:1991;172-176.
59. Touw M. The religious and medicinal uses of cannabis in China, India and Tibet. J Psychoactive Drugs. 13:1981;23-34.
60. Volicer L., Stelly M., Morris J., McLauglin C.L., Volicer B.J. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 12:1997;913-919.
61. 1) receptors. Psychopharmacology. 143:1999;315-317.
62. 9-THC. Physiol Behav. 65:1998;343-346.
63. York D.A. Regulation of feeding behavior: advances in understanding from molecular and physiologic approaches. Guy-Grand B., Ailhaud A. Recent Advances in Obesity Research. 1999;267-277 John Libbey, London.